Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.

Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.

Show other versions (1)

Neuraminidase inhibitors are the mainstay of anti-influenza treatment. Oseltamivir is the most widely used drug but is currently available only as an oral formulation. Resistance spreads rapidly in seasonal H1N1 influenza A viruses, which were universally resistant in 2008, because of the H275Y muta...

Full description

Bibliographic Details
Main Authors:	Chairat, K, Tarning, J, White, N, Lindegardh, N
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
by: Chairat, K, et al.
Published: (2013)

Neuraminidase inhibitors for influenza complications.
by: Del Mar, C, et al.
Published: (2014)

Towards optimal design of anti-malarial pharmacokinetic studies.
by: Simpson, J, et al.
Published: (2009)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Matheson, N, et al.
Published: (2003)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Matheson, N, et al.
Published: (2007)

Neuraminidase inhibitors for preventing and treating influenza in children
by: Wang, K, et al.
Published: (2012)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Wang, K, et al.
Published: (2012)

Exploring the chemical space of influenza neuraminidase inhibitors
by: Nuttapat Anuwongcharoen, et al.
Published: (2016-04-01)

Systematic review of influenza resistance to the neuraminidase inhibitors
by: Boivin Guy, et al.
Published: (2011-05-01)

Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01)

Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor.
by: Tomoko Nishikawa, et al.
Published: (2012-01-01)

Anti-neuraminidase immunity in the combat against influenza
by: Xiaojian Zhang, et al.
Published: (2024-12-01)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
by: Vernon J. Lee, et al.
Published: (2006-01-01)

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
by: Kamali A, et al.
Published: (2013-11-01)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
by: Jefferson, T, et al.
Published: (2014)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
by: Jefferson, T, et al.
Published: (2014)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
by: Toniolo Neto, J
Published: (2014)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
by: Tarning, J, et al.
Published: (2007)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
by: Tom Jefferson, et al.

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies
by: Natalia A. Ilyushina, et al.
Published: (2019-11-01)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
by: Jamsen, K, et al.
Published: (2011)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
by: Yacine Abed, et al.
Published: (2019-04-01)

Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection.
by: Takuro Mizuno, et al.
Published: (2014-01-01)

Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity
by: Pedro Laborda, et al.
Published: (2016-11-01)

NEURAMINIDASE INHIBITORS — THE GOLD STANDARD OF ANTIVIRAL INFLUENZA A THERAPY
by: V. V. TSVETKOV, et al.
Published: (2017-05-01)

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)
by: Wang, K, et al.
Published: (2012)

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
by: Wang, K, et al.
Published: (2012)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
by: Tarning, J, et al.
Published: (2008)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
by: Chairat, K, et al.
Published: (2016)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
by: Nipaporn Tewawong, et al.
Published: (2018-01-01)

THE STUDY OF INFLUENZA VIRUS NEURAMINIDASE HYDRATION DEGREE
by: N. S. Grebenkina, et al.
Published: (2018-01-01)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
by: Jamsen, K, et al.
Published: (2012)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
by: Seo, S, et al.
Published: (2013)

Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.
by: Andreas Handel, et al.
Published: (2007-12-01)

Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
by: Momoko Mawatari, et al.
Published: (2019-01-01)

Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
by: César Parra-Rojas, et al.
Published: (2018-08-01)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
by: Ali, S, et al.
Published: (2010)

The Synthetic Development of the Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu®): A Challenge for Synthesis & Process Research
by: Stefan Abrecht, et al.
Published: (2004-09-01)

Resistant machanisms, dynamic properties and inhibitor development of neuraminidase in influenza virus : molecular dynamics simulations studies
by: Han, Nanyu
Published: (2014)

Bifunctional Inhibitors of Influenza Virus Neuraminidase: Molecular Design of a Sulfonamide Linker
by: Sergei Evteev, et al.
Published: (2021-12-01)